Vivo Capital VIII, LLC's Net Worth

$57.1 Million

Who is Vivo Capital VIII, LLC?

Vivo Capital VIII, LLC has an estimated net worth of $57.1 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Menlo Therapeutics Inc., Aligos Therapeutics, Inc., Terns Pharmaceuticals, Inc., IMPEL NEUROPHARMA INC, Bolt Biotherapeutics, Inc., Kadmon Holdings, Inc., Nabriva Therapeutics plc, and BioPharmX Corp.

SEC CIK

Vivo Capital VIII, LLC's CIK is 0001618789

Past Insider Trading and Trends

2021 was Vivo Capital VIII, LLC's most active year for acquiring shares with 33 total transactions. Vivo Capital VIII, LLC's most active month to acquire stocks was the month of January. 2020 was Vivo Capital VIII, LLC's most active year for disposing of shares, totalling 37 transactions. Vivo Capital VIII, LLC's most active month to dispose stocks was the month of January. 2021 saw Vivo Capital VIII, LLC paying a total of $25,074,158.33 for 9,490,040 shares, this is the most they've acquired in one year. In 2019 Vivo Capital VIII, LLC cashed out on 744,870 shares for a total of $9,612,677.40, their largest year based on trade value.